Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 161

Sort by

Sort Order Select

Journal Articles

The journey of a thousand miles begins with 1 step

Luca Malcovati

Blood (2021) 138 (10): 824–826.

https://doi.org/10.1182/blood.2021012304

Published: 2021

Journal Articles

Pioglitazone Did Not Affect PPAR-Γ , STAT5 , HIF2α and CITED2 Gene Expression in Chronic Myeloid Leukemia Patients with Deep Molecular Response

Ana Beatriz Pascoal Lopes, Eliana C Miranda, PhD, Valquíria Mariane Oliveira Póvoa, Bruna Rocha Vergílio, Graziele Cristina Pavan Furlin, Marcia Torresan Delamain, MD, Gislaine Borba Duarte, MD, Carmino Antonio Souza, MD PhD, Erich V De Paula, MD PhD, Katia B Pagnano, MD PhD

Blood (2019) 134 (Supplement_1): 1637.

https://doi.org/10.1182/blood-2019-128265

Published: 2019

Journal Articles

Characterizing Dyskeratosis Congenita Caused By Parn Mutations in the Zebrafish

Anna Cordeiro, PhD, Adam P Deveau, MSc, Santhosh Dhanraj, PhD, Yigal Dror, MDFRCPC, Jason Berman, MD

Blood (2019) 134 (Supplement_1): 3744.

https://doi.org/10.1182/blood-2019-130147

Published: 2019

Journal Articles

Molecular Mechanisms of Primary Resistance to Azacitidine in MDS/AML Patients - Data of the Hellenic MDS Study Group

Vassiliki Mpakou, PhD, Aris Spathis, PhD, Anthi Bouhla, MD, Frieda Kontsioti, PhD, Zoi Tsakiraki, MD, Sotirios Papageorgiou, MD PhD, Efthimia Mpazani, MD, Irene Glezou, MD, Konstantinos Gkodopoulos, MD, Georgia Stavroulaki, MD, Athanasios Galanopoulos, MD PhD, Argiris Symeonidis, MD PhD, Nora-Athina Viniou, MD PhD, Kalliopi Zafeiropoulou, Ioannis Kotsianidis, MD PhD, Periklis Foukas, MD PhD, Vassiliki Pappa, MD

Blood (2019) 134 (Supplement_1): 5403.

https://doi.org/10.1182/blood-2019-122424

Published: 2019

Journal Articles

Comparison of RNA-Based Versus DNA-Based Quantitative KIT D816V Mutation Analysis Reveals Significant Disparity in Patients with Advanced Systemic Mastocytosis

Mohamad Jawhar, Nicole Naumann, Johannes Lübke, Juliana Schwaab, Oliver Hofmann, Thomas Kielsgaard Kristensen, Karl Sotlar, Verena Haselmann, Sven Schneider, Georgia Metzgeroth, Henning D. Popp, Alice Fabarius, PhD, Peter Bugert, Wolf-Karsten Hofmann, MD PhD, Andreas Reiter

Blood (2019) 134 (Supplement_1): 2955.

https://doi.org/10.1182/blood-2019-128811

Published: 2019

Journal Articles

Long Non-Coding RNAs As Novel Therapeutic Targets in Juvenile Myelomonocytic Leukemia: Proof of Concept Study

Mattias Hofmans, MD, Barbara Depreter, PhD PharmD, Tim Lammens, PhD, Helene Cave, PharmD, PhD, Christian Flotho, MD PhD, Henrik Hasle, Valerie de Haas, MD PhD, Charlotte M. Niemeyer, MD, Jan Stary, Prof., MD PhD, Pieter Van Vlierberghe, PhD, Jan Philippé, MD PhD, Barbara De Moerloose, MD PhD

Blood (2019) 134 (Supplement_1): 1701.

https://doi.org/10.1182/blood-2019-123715

Published: 2019

Journal Articles

Phase I/II Study of Ruxolitinib for Minimal Residual Disease in Chronic Myeloid Leukemia

Abhishek Maiti, MBBS, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD, Rebecca Poku, MPH, Brittany A Yearby, Stephanie Breakefield, RN, Farhad Ravandi, MD, Jorge E. Cortes, MD

Blood (2018) 132 (Supplement 1): 3009.

https://doi.org/10.1182/blood-2018-99-113972

Published: 2018

Journal Articles

CD34+ Derived Microparticles Regulate Apoptosis in Normal and Acute Myeloid Leukemia Cells

Angeliki Xagorari, PhD, Sarantis Tsetsakos, Bsc, Zoi Katana, Konstantinos Krikonis, undergraduate student, Anastasia Kouvatsi, Katerina Chlichlia, Assistant Professor, Achilles Anagnostopoulos, Damianos Sotiropoulos, MD

Blood (2018) 132 (Supplement 1): 5090.

https://doi.org/10.1182/blood-2018-99-114425

Published: 2018

Journal Articles

Telomere Length and Telomerase Complex Mutations Predict Fatal Treatment Toxicity after Stem Cell Transplantation in Patients with Myelodysplastic Syndrome

Mikko Myllymaki, MD PhD, Robert A. Redd, MS, Corey S. Cutler, MD MPH, Wael Saber, MD MS, Zhen-Huan Hu, MPH, Tao Wang, PhD, Stephen R. Spellman, Christopher J. Gibson, MD, Maxine M Chen, Esther Orr, David P. Steensma, MD, Joseph H. Antin, MD, Immaculata De Vivo, Donna S Neuberg, ScD, Suneet Agarwal, MDPhD, R. Coleman Lindsley, MD, PhD

Blood (2018) 132 (Supplement 1): 796.

https://doi.org/10.1182/blood-2018-99-117031

Published: 2018

Journal Articles

MiR-221 Sensitizes Chronic Myeloid Leukemia Cells to Imatinib By Targeting STAT5

Xiucai Xu, Sr., Doctor, Xiaoxiao Jiang, Lijun Xia, MD PhD

Blood (2018) 132 (Supplement 1): 5152.

https://doi.org/10.1182/blood-2018-99-118037

Published: 2018

Journal Articles

The Role of Shelterin Complex and Post-Translational Non-Enzymatic Modification in Telomere Maintenance in Chronic Myeloid Leukemia

Anna Deregowska, MSc, Katarzyna Pruszczyk, MD, Iwona Solarska, PhD, Ilona Seferynska, MD PhD, Marek Dudzinski, MD, Maciej Wnuk, PhD, Tomasz Stoklosa, MD PhD

Blood (2018) 132 (Supplement 1): 5426.

https://doi.org/10.1182/blood-2018-99-112879

Published: 2018

Journal Articles

Genetic Evidence for Involvement of Human Endogenous Retrovirus Herv-Fc1 in the Pathogenesis of MPNs

Vibe Skov, PhD, Katrine LM Schmidt, Kasper Mønsted Pedersen, MD, Bettina Hansen, Tobias Wirenfeldt Klausen, M.S., Torben A Kruse, Mads Thomassen, PhD, Lasse Kjær, PhD, Christina Ellervik, Associate Professor, MD PhD, Morten Holmstrøm, MD, Bjørn Nexø, Hans Carl Hasselbalch, Professor, dr.MD, Magdalena J Laska

Blood (2018) 132 (Supplement 1): 5488.

https://doi.org/10.1182/blood-2018-99-118080

Published: 2018

Journal Articles

Comprehensive Genetic Characterization of 63 Myeloid/Lymphoid Neoplasms Associated with Eosinophilia and Rearrangement of PDGFR-α, PDGFR-β, FGFR1 or PCM1-JAK2

Constance Regina Baer, PhD, Verena Muehlbacher, MD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2017) 130 (Supplement 1): 4219.

https://doi.org/10.1182/blood.V130.Suppl_1.4219.4219

Published: 2017

Journal Articles

The Association of Hif-1α Expression with Primary Resistance to Azacytidine in Patients with High Risk MDS — Preliminary Data of the Hellenic MDS Study Group

Vassiliki Mpakou, PhD, Aris Spathis, PhD, Anthi Bouhla, MD, Konstantinos Gkodopoulos, MD, Georgia Stavroulaki, MD, Irene Glezou, MD, Sotirios Papageorgiou, MD PhD, Efthimia Bazani, MD, Diamantina Vasilatou, MD, Nora Viniou, MD, Athanasios Galanopoulos, MD PhD, Kalliopi Zafeiropoulou, Kotsianidis Ioannis, Argiris Symeonidis, MD PhD, George Dimitriadis, MD, Vassiliki Pappa, MD

Blood (2017) 130 (Supplement 1): 3825.

https://doi.org/10.1182/blood.V130.Suppl_1.3825.3825

Published: 2017

Journal Articles

Sample Exchange to Standardize Molecular Monitoring for CML: The EUTOS Experience

Martin C. Müller, MD, Christian Dietz, PhD, Giuseppe Saglio, MD PhD, Francois-Xavier Mahon, MD PhD, Fabrizio Pane, MD, Andreas Hochhaus, MD, Nicholas C.P. Cross, PhD

Blood (2017) 130 (Supplement 1): 2874.

https://doi.org/10.1182/blood.V130.Suppl_1.2874.2874

Published: 2017

Journal Articles

Expression Levels of the TERT Gene Can be Used to Risk Stratify Aplastic Anemia Patients: Study in an Indian Cohort

Arati Khanna-Gupta, PhD, Durga Sarvepalli, Snigdha Majumder, Coral Karunakaran, Malini Manoharan, Shilpa Sudesh, Varun Bafna, Chirantan Bose, Ravi Gupta, K.S. Natraj, Sharat Damodar, MBBS, MD DM, Arkasubhra Ghosh, PhD

Blood (2017) 130 (Supplement 1): 4963.

https://doi.org/10.1182/blood.V130.Suppl_1.4963.4963

Published: 2017

Journal Articles

Measurement of Increase in Cereblon mRNA Level after Addition of Erythropoietin to Lenalidomide May Predict a Clinical Response to Combination of Both the Drugs in Patients with Lower-Risk Myelodysplastic Syndromes

Radka Bokorová, Jaroslav Polak, MSc, Arnost Kostecka, Anna Jonasova, MD PhD, Radana Neuwirtova, MD PhD, Tomas Stopka, MD PhD Assoc Proff, Marie Lauermannova, Jaroslav Cermak, MD PhD, Dana Mikulenkova, Zuzana Zemanova, PhD, Jana Brezinova, PhD, Ota Fuchs, PhD

Blood (2017) 130 (Supplement 1): 5295.

https://doi.org/10.1182/blood.V130.Suppl_1.5295.5295

Published: 2017

Journal Articles

Telomerase Inhibition with Imetelstat Eradicates β-Catenin Activated Blast Crisis Chronic Myeloid Leukemia Stem Cells

Wenxue Ma, MD, PhD, Cayla N Mason, BS, Ping Chen, MD PhD, Nathaniel Delos Santos, BS, Jiang Qingfei, PhD, Elisa Lazzari, PhD, Fei Huang, Larisa Balaian, PhD, Catriona H.M. Jamieson, MD PhD

Blood (2016) 128 (22): 3065.

https://doi.org/10.1182/blood.V128.22.3065.3065

Published: 2016

Journal Articles

Mutations in the Telomerase Complex and Expression Levels of the TERT Gene Determine Severity and Outcome of Disease in Aplastic Anemia Patients

Arati Khanna-Gupta, MSc, PhD, Durga Sarvepalli, PhD, Snigdha Majumder, M.Tech, Coral Karunakaran, PhD, Malini Manoharan, PhD, Shilpa Prabhu, MBBS, MD, Varun Bafna, III, MBBS,DNB, Sakthivel Murugan SM, PhD, Chirantan Bose, MD(Path), Ravi Gupta, PhD, Nataraj KS, MD DM, Sharat Damodar, MD DM, Arkasubhra Ghosh, PhD

Blood (2016) 128 (22): 1502.

https://doi.org/10.1182/blood.V128.22.1502.1502

Published: 2016

Journal Articles

Optimization of CSF3R Mutation Detection in Severe Congenital Neutropenia and Cyclic Neutropenia Patients for Routine Diagnostics Using Next Generation Sequencing

Maksim Klimiankou, PhD, Cornelia Zeidler, MD, Sabine Mellor-Heineke, Ingeborg Steiert, Karin Haehnel, Karl Welte, MD PhD, Julia Skokowa, MD PhD

Blood (2016) 128 (22): 3685.

https://doi.org/10.1182/blood.V128.22.3685.3685

Published: 2016

NARROW

The journey of a thousand miles begins with 1 step

Pioglitazone Did Not Affect PPAR-Γ , STAT5 , HIF2α and CITED2 Gene Expression in Chronic Myeloid Leukemia Patients with Deep Molecular Response

Characterizing Dyskeratosis Congenita Caused By Parn Mutations in the Zebrafish

Molecular Mechanisms of Primary Resistance to Azacitidine in MDS/AML Patients - Data of the Hellenic MDS Study Group

Comparison of RNA-Based Versus DNA-Based Quantitative KIT D816V Mutation Analysis Reveals Significant Disparity in Patients with Advanced Systemic Mastocytosis

Long Non-Coding RNAs As Novel Therapeutic Targets in Juvenile Myelomonocytic Leukemia: Proof of Concept Study

Phase I/II Study of Ruxolitinib for Minimal Residual Disease in Chronic Myeloid Leukemia

CD34+ Derived Microparticles Regulate Apoptosis in Normal and Acute Myeloid Leukemia Cells

Telomere Length and Telomerase Complex Mutations Predict Fatal Treatment Toxicity after Stem Cell Transplantation in Patients with Myelodysplastic Syndrome

MiR-221 Sensitizes Chronic Myeloid Leukemia Cells to Imatinib By Targeting STAT5

The Role of Shelterin Complex and Post-Translational Non-Enzymatic Modification in Telomere Maintenance in Chronic Myeloid Leukemia

Genetic Evidence for Involvement of Human Endogenous Retrovirus Herv-Fc1 in the Pathogenesis of MPNs

Comprehensive Genetic Characterization of 63 Myeloid/Lymphoid Neoplasms Associated with Eosinophilia and Rearrangement of PDGFR-α, PDGFR-β, FGFR1 or PCM1-JAK2

The Association of Hif-1α Expression with Primary Resistance to Azacytidine in Patients with High Risk MDS — Preliminary Data of the Hellenic MDS Study Group

Sample Exchange to Standardize Molecular Monitoring for CML: The EUTOS Experience

Expression Levels of the TERT Gene Can be Used to Risk Stratify Aplastic Anemia Patients: Study in an Indian Cohort

Measurement of Increase in Cereblon mRNA Level after Addition of Erythropoietin to Lenalidomide May Predict a Clinical Response to Combination of Both the Drugs in Patients with Lower-Risk Myelodysplastic Syndromes

Telomerase Inhibition with Imetelstat Eradicates β-Catenin Activated Blast Crisis Chronic Myeloid Leukemia Stem Cells

Mutations in the Telomerase Complex and Expression Levels of the TERT Gene Determine Severity and Outcome of Disease in Aplastic Anemia Patients

Optimization of CSF3R Mutation Detection in Severe Congenital Neutropenia and Cyclic Neutropenia Patients for Routine Diagnostics Using Next Generation Sequencing

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only